Chronic osteomyelitis: Detection with FDG PET and correlation with histopathologic findings

Radiology

Volumn 206, Issue 3, 1998, Pages 749-754

  Guhlmann, Albrecht ^a   Brecht Krauss, Doris ^a   Suger, Gerbard ^a   Glatting, Gerhard ^a   Kotzerke, Joerg ^a   Kinzl, Lothar ^a   Reske, Sven N ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Bones, emission CT (ECT); Bones, infection; Bones, radionuclide studies; Fluorine; Soft tissues, infection

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GERMANIUM; MEDRONATE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CHRONIC OSTEOMYELITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SKELETON;

EID: 0031931955     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.206.3.9494496     Document Type: Article

References (60)

1. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations, and unusual aspects. N Engl J Med 1970; 282:198-206.
2. Tumeh S, Aliabadi P, Weissman B, McNeil B. Disease activity in osteomyelitis: role of radiography. Radiology 1987; 165:781-784.
3. Al-Sheikh W, Sfakianakis GN, Mnaymneh W, et al. Subacute and chronic bone infections: diagnosis using In-111, Ga-67, and Tc-99m MDP bone scintigraphy and radiography. Radiology 1985; 155:501-506.
4. McAfee JG. What is the best method for imaging focal infections? (editorial). J Nucl Med 1990; 31:413-416.
5. Schauwecker D. The scintigraphic diagnosis of osteomyelitis. AJR 1992; 158:9-18.
6. Elgazzar AH, Abdel-Dayem HM, Clark JD, Maxon HR III. Multimodality imaging of osteomyelitis. Eur J Nucl Med 1995; 22:1043-1063.
7. Palestro CJ, Chun CK, Swyer AJ, Vallabhajosula S, Goldsmith SJ. Radionuclide diagnosis of vertebral osteomyelitis: indium-111 leukocyte and technetium-99m-methylene diphosphonate bone scintigraphy. J Nucl Med 1991; 32:1861-1865.
8. Palestro JP. The current role of gallium imaging in infection. Semin Nucl Med 1994; 24:128-141.
9. Schauwecker DS. Osteomyelitis: diagnosis with In-111-labeled leukocytes. Radiology 1989; 171:141-146.
10. 99mTc)HMPAO-leukocytes for imaging infection. Semin Nucl Med 1994; 24:110-127.
11. Datz FL. Indium-111-labeled leukocytes for the detection of infection: current status. Semin Nucl Med 1994; 24:92-109.
12. Krznaric E, De Roo M, Verbruggen A, Stuyck J, Mortelmans L. Chronic osteomyelitis: diagnosis with technetium-99m-d,l-hexamethylpropylene amine oxime labelled leucocytes. Eur J Nucl Med 1996; 23:792-797.
13. Sciuk J, Brandau W, Vollet B, et al. Comparison of technetium 99m polyclonal human immunoglobin and technetium 99m monoclonal antibodies for imaging chronic osteomyelitis: first clinical results. Eur J Nucl Med 1991; 18:401-407.
14. Reuland P, Winker KH, Heuchert T, et al. Detection of infection in postoperative orthopedic patients with technetium-99m-labeled monoclonal antibodies against granulocytes. J Nucl Med 1991; 32:2209-2214.
15. Hotze AL, Briele B, Overbeck B, et al. Technetium-99m-labeled anti-granulocyte antibodies in suspected bone infections. J Nucl Med 1992; 33:526-531.
16. Becker W, Goldenberg DM, Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Semin Nucl Med 1994; 24:142-153.
17. Kaim A, Maurer T, Ochsner P, Jundt G, Kirsch E, Mueller-Brandt J. Chronic complicated osteomyelitis of the appendicular skeleton: diagnosis with technetium-99m labelled monoclonal antigranulocyte antibody-immunoscintigraphy. Eur J Nucl Med 1997; 24:732-738.
18. Palestro CJ, Swyer AJ, Kim CK, Goldsmith SJ. Infected knee prosthesis: diagnosis with In-111 leukocyte, Tc-99m sulfur colloid, and Tc-99m MDP imaging. Radiology 1991; 179:645-648.
19. Palestro CJ, Roumanas P, Swyer AJ, Kim CK, Goldsmith SJ. Diagnosis of musculoskeletal infection using combined In-111 labeled leukocyte and Tc-99m SC marrow imaging. Clin Nucl Med 1992; 17:269-273.
20. Achong DM, Oates E. The computer-generated bone marrow subtraction image: a valuable adjunct to combined In-111 WBC/Tc-99m in sulfur colloid scintigraphy for musculoskeletal infection. Clin Nucl Med 1994; 19:188-193.
21. Jacobsen AF, Gilles CP, Cerqueira MD. Photopenic defects in marrow-containing skeleton on indium-111 leucocyte scintigraphy: prevalence at sites suspected of osteomyelitis and as an incidental finding. Eur J Nucl Med 1992; 19:858-864.
22. Datz FL, Thorne DA. Cause and significance of cold bone defects on indium-111-labeled leukocyte imaging. J Nucl Med 1987; 28:820-823.
23. Even-Sapir E, Martin RH. Degenerative disc disease: a cause for diagnostic dilemma on In-111 WBC studies in suspected osteomyelitis. Clin Nucl Med 1994; 19:388-392.
24. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
25. Jones HA, Clark RJ, Rhodes CG, Schofield JB, Krausz T, Haslett C. In vivo measurement of neutiophil activity in experimental lung inflammation. Am J Respir Crit Care Med 1994; 149:1635-1639.
26. Borregard N, Herlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 1982; 70:550-557.
27. Palmer WE, Rosenthal DI, Schoenberg OI, et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-(F-18)-fluoro-2-deoxy-D-glucose. Radiology 1995; 196:647-655.
28. 18F)-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989; 13:829-831.
29. 18F)-FDG in brain abscess: a PET study. J Comput Assist Tomogr 1990; 14:486-487.
30. Lewis PJ, Salama A. Uptake of fluorine-18-deoxyglucose in sarcoidosis. J Nucl Med 1994; 35:1647-1649.
31. Brudin LH, Valind SO, Rhodes CG, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994; 21:297-305.
32. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules: potential role in evaluation and management. Chest 1993; 104:997-1002.
33. 18F)FDG positron emission tomography (PET). Thorax 1997; 52:438-441.
34. Stollfuss JC, Glatting G, Friess H, Kocher F, Beger HG, Reske SN. 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology 1995; 195:339-344.
35. Schmidlin P. Improved iterative image reconstruction using variable projection binning and abbreviated convolution. Eur J Nucl Med 1994; 21:930-936.
36. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
37. Müller SP, Reiners C. Studies and recommendations on the design of ROC analyses in nuclear medicine. Nuklearmedizin 1995; 34:24-31. [German]
38. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189:847-850.
39. Crim JR, Seeger LL. Imaging evaluation of osteomyelitis. Crit Rev Diagn Imaging 1994; 35:201-256.
40. Tehranzadeh J, Wang F, Mesgarzadeh M. Magnetic resonance imaging of osteomyelitis. Crit Rev Diagn Imaging 1992; 33:495-534.
41. Unger E, Moldofsky P, Gatenby R, Hartz W, Broder G. Diagnosis of osteomyelitis by MR imaging. AJR 1988; 150:605-610.
42. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36:1301-1306.
43. 18F)-fluorodeoxyglucose and positron emission tomography. Lancet 1996; 347:937-940.
44. Kolindou A, Liu Y, Ozker K, et al. In-111 WBC imaging of osteomyelitis in patients with underlying bone scan abnormalities. Clin Nucl Med 1996; 21:183-191.
45. Schauwecker DS, Park HM, Mock BH, et al. Evaluation of complicating osteomyelitis with Tc-99m MDP, In-111 granulocytes, and Ga-67 citrate. J Nucl Med 1984; 25:849-853.
46. Van Nostrand D, Abreu SH, Callaghan JJ, Atkins FB, Stoops HC, Savory CG. In-111-labeled white blood cell uptake in noninfected closed fracture in humans: prospective study. Radiology 1988; 167:495-498.
47. 111In leukocyte scintigraphy. AJR 1987; 148:927-930.
48. Seabold JE, Nepola JV, Marsh JL, et al. Postoperative bone marrow alterations: potential pitfalls in the diagnosis of osteomyelitis with In-111-labeled leukocyte scintigraphy. Radiology 1991; 180:741-747.
49. Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993; 34:1190-1197.
50. Jones SC, Alavi A, Christman D, Montanez I, Wolf AP, Reivich M. The radiation dosimetry of 2-(F-18)fluoro-2-deoxy-D-glucose in man. J Nucl Med 1982; 23:613-617.
51. 99mTc-HMPAO-labeled leukocytes. Acta Radiol 1996; 37:870-876.
52. Gratz S, Braun HG, Behr TM, et al. Photopenia in chronic vertebral osteomyelitis with technetium-99m-antigranulocyte antibody (BW 250/ 183). J Nucl Med 1997; 38:211-216.
53. Reske SN, Karstens JH, Gloeckner W, et al. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet 1989; 2:299-301.
54. Chung JK, Yeo J, Lee DS, et al. Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders. J Nucl Med 1996; 37:978-982.
55. Warburg O. The metabolism of tumors. New York, NY: Richard R. Smith, 1931; 129-169.
56. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32:623-648.
57. 18F)fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 1993; 17:582-589.
58. Reske SN, Bares R, Büll U, Guhlmann A, Moser E, Wannenmacher MF. Klinische wertigkeit der positronen-emissions-tomographie (PET) bei onkologischen fragestellungen: ergebnisse einer interdisziplinären konsensuskonferenz. Nuklearmedizin 1996; 35:42-52.
59. 18F)-FDG in oncology: a clinical update. Nucl Med Biol 1996; 23:717-735.
60. Dehdashti F, Siegel BA, Griffeth LK, et al. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-(F-18)fluoro-2-deoxy-D-glucose. Radiology 1996; 200:243-247.